Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/25/2010US20100298428 Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
11/25/2010US20100298427 Anti-inflammatory compositions and their use
11/25/2010US20100298426 Therapeutic agent for substance dependence
11/25/2010US20100298425 Use of Tocotrienols for Elevating IKBKAP Gene Expression and Treating Familial Dysautonomia
11/25/2010US20100298424 Method for treating abdominal discomfort
11/25/2010US20100298423 Nutraceutical composition from garcinia mangostana
11/25/2010US20100298422 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same
11/25/2010US20100298421 Derivatives of taxol and closely related compounds
11/25/2010US20100298420 Compositions and Methods for Intracellular Delivery
11/25/2010US20100298419 Antibiotic-free plasmid
11/25/2010US20100298418 Assay for measuring plasma FGL-2 and methods and uses thereof
11/25/2010US20100298417 Modulation of factor 7 expression
11/25/2010US20100298416 Preventing hyaluronan-mediated tumorigenetic mechanisms using intronic rnas
11/25/2010US20100298415 Targeted schiff base complexes
11/25/2010US20100298414 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100298413 Use of oligotide for the treatment of renal diseases
11/25/2010US20100298412 Disulfide Chemotherapeutic Agents and Methods of Use Thereof
11/25/2010US20100298411 Lipid-modified double-stranded rna having potent rna interference effect
11/25/2010US20100298410 MICROMIRs
11/25/2010US20100298409 Compositions comprising stat3 sirna and methods of use thereof
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100298407 Compositions and methods featuring micronas for treating neoplasia
11/25/2010US20100298406 Method of suppressing tumour growth
11/25/2010US20100298405 Compositions And Methods For Inhibiting Expression Of Huntingtin Gene
11/25/2010US20100298404 Translocation and mutant ROS kinase in human non-small cell lung carcinoma
11/25/2010US20100298403 MODIFIED POLY(PROPYLENE-IMINE) DENDRIMERS AND THEIR USE AS TRANSFECTION AGENTS FOR AMIONIC BIOACTIVE FACTORS ( as amended
11/25/2010US20100298402 Stilbene derivatives as pstat3/il-6 inhibitors
11/25/2010US20100298401 Galenical form for the administration of triptans by buccal transmucous means
11/25/2010US20100298400 Salts of perindopril
11/25/2010US20100298399 Endothelin Single Nucleotide Polymorphisms and Methods of Predicting B-Adrenergic Receptor Targeting Agent Efficacy
11/25/2010US20100298398 Thrombopoietin receptor agonist (tpora) kills acute human myeloid leukemia cells
11/25/2010US20100298397 Method of treatment of obsessive compulsive disorder with ondansetron
11/25/2010US20100298396 MANUFACTURE, COMPOSITIONS AND USES OF COAGULATION FACTOR VIIa MODULATOR
11/25/2010US20100298395 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
11/25/2010US20100298394 Antifungal agents as neuroprotectants
11/25/2010US20100298393 Modulation of Growth Hormone, DHEA, and Cortisol with Positive Modulators of AMPA Type Glutamate Receptors
11/25/2010US20100298392 Isoindoline Derivatives For The Treatment Of Arrhythmias
11/25/2010US20100298391 Amide compounds and use thereof for plant disease control
11/25/2010US20100298390 Inhibition of lethal factor protease activity from anthrax toxin
11/25/2010US20100298389 Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders
11/25/2010US20100298388 Substituted benamidines as antibacterial agents
11/25/2010US20100298387 IL-8 Receptor Antagonists
11/25/2010US20100298386 Compositions and methods for treating mastitis
11/25/2010US20100298385 Protein kinase inhibitors useful for treatment of cancers
11/25/2010US20100298384 Novel oxazolidinone compounds as antiinfective agents
11/25/2010US20100298383 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
11/25/2010US20100298382 Compositions and methods for alleviating depression or improving cognition
11/25/2010US20100298381 Gamma secretase modulators
11/25/2010US20100298380 N-aryl-n-piperidin-4-ylmethyl-amide derivatives and thier use as monoamine neurotransmitter re-uptake inhibitors
11/25/2010US20100298379 Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound
11/25/2010US20100298378 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/25/2010US20100298377 Novel substituted indazoles, the preparation thereof and use of same in therapeutics
11/25/2010US20100298376 Use of novel neuroprotective 3-substituted indolone compositions
11/25/2010US20100298375 medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
11/25/2010US20100298374 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010US20100298373 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
11/25/2010US20100298372 Gamma secretase modulators
11/25/2010US20100298371 Process for preparing chemically and chirally pure solifenacin base and its salts
11/25/2010US20100298370 Benzothiazolyl thienopyridine derivatives and uses thereof
11/25/2010US20100298369 Berbamine derivatives
11/25/2010US20100298368 Antagonists of pgd2 receptors
11/25/2010US20100298367 Conformationally Constrained Carboxylic Acid Derivatives Useful for Treating Metabolic Disorders
11/25/2010US20100298366 Chemokine receptor binding compounds
11/25/2010US20100298365 Topical administration carrier composition and therapeutic formulations comprising same
11/25/2010US20100298364 salts 756
11/25/2010US20100298363 Use of carboxyamidotriazole (CAI) orotate in macular degeneration
11/25/2010US20100298362 Process for the preparation of 4-[6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
11/25/2010US20100298361 Alkylthio Pyrimidines As CRTH2 Antagonists
11/25/2010US20100298360 Small molecule inhibitors of pdz interactions
11/25/2010US20100298359 Gamma secretase modulators
11/25/2010US20100298358 Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors
11/25/2010US20100298357 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
11/25/2010US20100298355 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010US20100298354 Crystalline Form Of Abacavir That Is Essentially Free Of Solvent
11/25/2010US20100298353 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
11/25/2010US20100298352 Small molecule inhibitors of cancer stem cells
11/25/2010US20100298351 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti-cancer agents
11/25/2010US20100298350 Triazolo[4,5-D]Pyrimidine Compounds For Treatment Of Abdominal Aortic Aneurysms
11/25/2010US20100298349 Thienopyrimidine compounds and compositions
11/25/2010US20100298348 Method of Decreasing Ubiquitylated Protein Levels
11/25/2010US20100298347 Substituted 2-naphthoic acids as antagonists of gpr105 activity
11/25/2010US20100298345 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
11/25/2010US20100298344 Polycationic Compounds And Uses Thereof
11/25/2010US20100298343 5-lipoxygenase-activating protein (flap) inhibitors
11/25/2010US20100298342 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease
11/25/2010US20100298341 Glycine Transporter-1 Inhibitors
11/25/2010US20100298340 Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies
11/25/2010US20100298339 [1,2,4]Triazolo[1,5-a]Pyridine and [1,2,4]Triazolo[1,5-c]Pyrimidine Compounds and Their Use
11/25/2010US20100298338 Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor kit
11/25/2010US20100298337 Organic Compounds
11/25/2010US20100298336 Pyrimidines as novel therapeutic agents
11/25/2010US20100298335 Preparations and Methods for Ameliorating or Reducing Presbyopia
11/25/2010US20100298334 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
11/25/2010US20100298333 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/25/2010US20100298332 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands
11/25/2010US20100298331 Triazinone and diazinone derivatives useful as hsp90 inhibitors
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/25/2010US20100298329 Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers
11/25/2010US20100298328 1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes
11/25/2010US20100298327 Aprepitant polymorph mixtures
1 ... 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 ... 7860